JADA Continuing Education
Treatment of patients who have type 1 diabetes mellitus
Physiological misconceptions and infusion pump therapy
JOHN R. KEENE, D.M.D.,
STEVEN I. KALTMAN, D.M.D., M.D. and
HOWARD M. KAPLAN, M.D., D.D.S., M.S.
 |
ABSTRACT
|
|---|
Background. This article reviews the unique physiology of patients who have type 1 diabetes mellitus (insulin-dependent diabetes mellitus, or IDDM); allays some common physiological misconceptions; and updates dental practitioners on the emerging technology of insulin infusion pump therapy, now available to patients who have type 1 diabetes mellitus.
Description. The authors review the physiology of stress and describe the dawn phenomenon. They also describe insulin infusion pump therapy, as well as its advantages and disadvantages, to familiarize dentists with new technologies in caring for patients who have diabetes. Emergencies that may present themselves as a result of these advances in biotechnology are discussed.
Clinical Implications. Dental practitioners who treat patients who have IDDM need to have a solid foundation in the basic medical sciences and emerging biomedical technology as they each relate to diabetes. Practitioners must become familiar with infusion pump therapy, not only for cases of medical emergencies, but also to customize treatment for patients who have diabetes. Practitioners also need to remain up to date in the rapidly changing realm of caring for people who have diabetes.
The literature is replete with articles discussing type 1 diabetes mellitus (insulin-dependent diabetes mellitus, or IDDM) and the medical and dental treatment of patients who have diabetes. Dentists and dental students are educated about diabetes through lectures, current literature, continuing education courses and hospital seminars. Some important goals of these activities are to inform clinicians about changes in the management of diabetes, medical emergencies that may arise when treating patients who have diabetes and the relevant basic medical sciences that support treatment.
As more patients who have type 1 diabetes mellitus will be using intensive therapy and insulin pump infusion, dentists need to familiarize themselves with insulin infusion pump therapy.
Hypoglycemia is a common emergency that occurs during the dental treatment of patients who have diabetes. Dentists are trained to recognize and treat hypoglycemia; its common warning signs are confusion, agitation, tremors, tachycardia, diaphoresis, dizziness, unconsciousness and, if treated improperly, death.1 The best treatment for hypoglycemia is prevention.2,3
Advances in biomedical technology now give people who have diabetes improved control over their daily lives. As new forms of insulin, methods of insulin delivery and monitoring of blood glucose have become available, people who have diabetes are able to maintain their blood-glucose levels at more satisfactory and safer levels.
Because of the ongoing biodigital revolution and the importance of continuing to deliver quality oral health care to patients, we present a discussion and update of the basic medical sciences as they relate to diabetes, as well as their integration into clinical dentistry.
 |
STRESS AND THE PHYSIOLOGY OF HYPOGLYCEMIA
|
|---|
"Stress," "anxiety" and "fear" are words that many patients associate with visits to their dentists. A common and important misconception of dentists is that the acute stress of a dental visit in an anxious patient who has diabetes causes hypoglycemia.4
Instead, the major glycemic effect of stress is an increase in blood-glucose levels, which causes the release of catecholamines, primarily epinephrine, into the bloodstream.5 Different types of stressincluding anxiety, fear, exercise, pain and trauma, as well as hypoxia, hypothermia, hypotension and hypoglycemiastimulate this release. Acute stress, such as that occurring during a dental visit, stimulates the sympathetic splanchnic nerves that induce the release of large amounts of catecholamines (primarily epinephrine) from the adrenal medulla. This sympathetic-adrenergic system prepares the body for "flight or fight," the acute stress reactions.6 In people who do not have diabetes, the alpha and beta cells, in turn, exert negative feedback on each other to maintain normal blood sugar levels and to prevent hypoglycemia.
Clinicians can prevent hypoglycemic attacks from occurring in the dental office by talking with patients who have type 1 diabetes mellitus about their insulin intake before dental appointments.
In all people, a stress-induced catecholamine increase prepares the body for "fight or flight," inducing the release of glucose by stimulating glycogenolysis, increasing lipolysis and inhibiting peripheral glucose uptake. In patients who have IDDM, however, no insulin is produced by the beta cells of the pancreas. Since insulin is not available in these patients to antagonize the alpha cells release of glucagon, the alpha cells are down-regulated owing to the islet cells paracrine action and, therefore, produce less glucagon.7
Catecholamine release due to stress, thus, becomes a major counter-regulatory mechanism to the exogenous insulin taken by the patient who has diabetes. It can be seen, then, that the release of catecholamines in a stressed patient who has diabetes causes blood sugar levels to increase.8,9
Patients who have type 1 diabetes mellitus develop hypoglycemia during stressful dental visits for the same reason that it develops at any timebecause there is an excess amount of exogenous insulin relative to blood glucose.2 Excess insulin stimulates glycogenesis and simultaneously stops the production of new glucose, which results in a decrease in blood glucose even in the presence of catecholamines.6 A patient who has diabetes, therefore, first will have an increase in blood sugar levels, caused by the influences of stress-induced catecholamine release. This is followed by a steep drop in blood-glucose levels, precipitated by excess exogenous insulin.
 |
DENTAL APPOINTMENTS AND THE DAWN PHENOMENON
|
|---|
Clinicians can prevent hypoglycemic attacks from occurring in the dental office by talking with patients who have type 1 diabetes mellitus about their insulin intake before dental appointments.
Clinicians usually schedule patients who have diabetes for morning appointments and instruct them to eat their usual breakfasts and take their insulin.4,10 These instructions, however, do not apply to all patients who have IDDM. People have different lifestyles, and patients who have type 1 diabetes mellitus are no exception. They tailor their meals, insulin administration, and work and exercise routines in many different ways with the guidance of their physicians and dietitians. Many patients who have diabetes and are on strict control regimens choose not to eat breakfast and are able to adjust their insulin dosages accordingly and successfully. There are variations in the types of insulin a patient may administer, including onset, peak time and duration of action. Insulin administration methods also vary from subcutaneous insulin injections to the increasing use of insulin pumps.11 To instruct every patient who has type 1 diabetes mellitus to eat a meal and administer insulin before morning dental appointments does not conform to current technology. Clinicians need to have a solid understanding of the basic medical sciences as they apply to diabetes mellitus so they can advise a patient properly regarding special preparations before a dental appointment.
The hyperglycemic reaction known as the "dawn phenomenon" is the physiological basis for scheduling a morning dental appointment for patients who have type 1 diabetes mellitus. The dawn phenomenon is morning hyperglycemia without an antecedent hypoglycemia. It is an event exclusive to patients who have type 1 diabetes mellitus and usually occurs between 5 a.m. and 9 a.m. It is caused by the rise of nocturnal growth hormone secretion with the subsequent stimulation of gluconeogenesis by the liver.12 Therefore, on waking, patients who have type 1 diabetes mellitus have relative hypoinsulinemia with expected increases in blood glucose. Significant early morning blood-glucose elevations generally occur owing to a combination of the dawn phenomenon and normally high morning levels of endogenous cortisol. These dawn elevations may be treated with combinations of insulin or by adjusting the basal rates and times of an insulin pump. The dawn phenomenon is a major physiological rationale behind scheduling patients who have IDDM for morning appointments. The principle that cannot be stressed enough, however, is that having patients who have type 1 diabetes mellitus follow their "normal routines" is essential in the prevention of hypoglycemia.
 |
TECHNOLOGICAL ADVANCES IN CARE OF PEOPLE WHO HAVE DIABETES
|
|---|
Little has been written in the dental literature about the treatment of patients who have IDDM and use insulin infusion pump therapy. The insulin pump is a beeper-sized device that delivers insulin to the patient through an indwelling subcutaneous catheter (Figure 1
and Figure 2
). The catheter is changed three to four times each week and is inserted with the help of a penlike insertion device (Figure 3
). The Diabetes Control and Complications Trial, or DCCT, of 1993 proved that intensive therapy (insulin infusion pump therapy or three to four insulin injections daily) showed significant reductions in the long-term complications of diabetes mellitus, including retinopathy, nephropathy and neuropathy.9

View larger version (102K):
[in this window]
[in a new window]
|
Figure 1. A typical insulin pump is a beeper-sized device usually worn at the patients belt line. The buttons that control the action of the pump can be seen clearly and are accessed easily by the patient.
| |
Today, many patients are under intensive therapy with the aid of personal digital glucometers, carbohydrate counting, insulin dose adjustments and long-term monitoring of glucose control with HbA1c levels. This has led to far greater blood-glucose control than in the past. According to the DCCT, intensive therapy also has led to an approximately three times greater incidence of hypoglycemia because of tighter blood-glucose control.11 With newer technology and a greater understanding of insulin pump therapy, statistics now are showing decreases in the incidence of hypoglycemia in patients who have type 1 diabetes mellitus and are under intensive therapy.13
There are 1 million people who have type 1 diabetes mellitus in the United States, and approximately 200,000 of them use insulin pumps (Oral communication, Ray Hoese, director of marketing communications, Medtronic MiniMed, Northridge, Calif., March 2002). Practitioners need to be familiar with the way the insulin pumps work and understand their advantages and disadvantages (Box
). They also must be aware of the increased incidences of hypoglycemia caused by intensive therapy and know how to treat hypoglycemic patients who have diabetes. The emergency treatment of patients using different insulin delivery systems requires constant updating.
There are many advantages to insulin pump therapy. The greatest, from the perspective of the pump user, is the flexibility in lifestyle that the infusion pump allows. Infusion pumps eliminate the need for multiple daily insulin injections by delivering a basal rate of insulin that can be programmed to coordinate insulin delivery with patients daily lifestyles. The pump is able to circumvent the problems associated with the dawn phenomenon, thus rendering it unnecessary for people to wake up early and deliver their long-lasting morning insulin injections.14
Dental practitioners need to be familiar with insulin pump therapy to deal effectively with complications that may arise in their patients who have IDDM and who use the pump. One of the major risks of infusion pump therapy is the development of hyperglycemia caused by pump failure or a kink in the infusion line. Although current pumps have built-in alarms to safeguard against kinks in the lines, cases of ketoacidosis have occurred relatively quickly in pump users because the pump is the sole source of insulin.14 Practitioners need to know the signs and symptoms of hyperglycemia and how to treat it. Practitioners must be certain that their patients who have diabetes bring their glucometers with them to every appointment and take their blood-glucose level readings before dental treatment or more frequently if indicated. Cases of severe hypoglycemia also have been reported with pump users, especially when patients first switch to pump therapy. This is due to the fact that insulin is being infused constantly at a preprogrammed rate. If the patient has not eaten enough or if the basal rate of insulin is set too high, the patient will become hypoglycemic rapidly.
If office emergencies arise that involve patients who have diabetes and are receiving infusion pump therapy, the clinician needs to quickly determine the nature of the emergency (that is, hypoglycemia vs. hyperglycemia). Since the majority of these emergencies will be cases of hypoglycemia, the clinician or patient should always place the insulin pump on "suspend" mode immediately. This will prevent more insulin from being pumped into the patient. A quick blood-glucose level check with the patients glucometer then can be performed to verify the diagnosis. The dentist or patient then needs to check the pumps function after glucose levels return to normal. In instances of an unconscious patient who has hypoglycemia, the dentist must immediately suspend the flow of insulin into the patient and quickly administer glucagon subcutaneously (a solution of intravenous 50 percent dextrose also is acceptable if an intravenous line is already in place). A properly equipped in-office emergency kit should include a disposable glucagon injection set for unconscious patients who have diabetes.2
 |
CONCLUSION
|
|---|
Dental practitioners treating patients who have IDDM need to have a solid foundation in both the basic medical sciences and emerging biomedical technology as they relate to diabetes mellitus. This will enable practitioners to provide quality oral health care in a safe and monitored environment. Both medical and dental treatment must be customized for the needs of each patient who has diabetes.
As more patients who have type 1 diabetes mellitus will be using intensive therapy and insulin pump infusion, dentists also need to familiarize themselves with insulin infusion pump therapy and its advantages and disadvantages. Clinicians may find themselves encountering unfamiliar medical emergencies caused by the use of infusion pumps. It is essential that practitioners remain current regarding the basic medical science and biomedical technology of diabetes care. Patients and the profession demand it.
 |
FOOTNOTES
|
|---|
Dr. Keene is a resident, Oral and Maxillofacial Surgery, Westchester Medical Center, Valhalla, N.Y. He was a senior dental student, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, Fla., when this article was written. Address reprint requests to Dr. Keene at Westchester Medical Center, Department of Oral and Maxillofacial Surgery, Macy Pavilion, Valhalla, N.Y. 10595, e-mail "jrkeene7{at}aol.com".
Dr. Kaltman is a professor and the chair, Department of Oral and Maxillofacial Surgery, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, Fla.
Dr. Kaplan is a professor and the chair, Department of Oral Medicine, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, Fla.
 |
REFERENCES
|
|---|
- Mealey BL. Impact of advances in diabetes care on dental treatment of the diabetic patient. Compend Contin Educ Dent 1998;19:4150.
- Service FJ. Hypoglycemia. Med Clin North Am 1995;79(1):18.[Medline]
- Cryer PE. Hypoglycemic risk reduction in type 1 diabetes. Exp Clin Endocrinol Diabetes 2001;109(supplement 2):S41223.
- Committee on Research, Science and Therapy. American Academy of Periodontology. Diabetes and periodontal diseases. J Periodontol 2000;71:66478.[Medline]
- Surwit RS, Schneider MS. Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 1993;55(4):38093.[Abstract/Free Full Text]
- Davidson JK. Clinical diabetes mellitus: A problem oriented approach. 2nd ed. New York: Theime Medical; 1991:1713.
- Devlin T, ed. Textbook of biochemistry with clinical correlations. 4th ed. New York: Wiley-Liss; 1997:5501.
- Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000;43:53349.[Medline]
- Berk MA, Clutter WE, Skor D, et al. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 1985;75:184251.
- Lalla RV, DAmbrosio JA. Dental management considerations for the patient with diabetes mellitus. JADA 2001;132:142532.
- DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Eng J Med 1993;329:97786.[Abstract/Free Full Text]
- Campbell CJ, Bolli GB, Cryer PE, Gerich JE. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Eng J Med 1985;312:14739.[Abstract]
- Boland EA, Grey M, Oesterle A, Frederickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22(11):177984.[Abstract/Free Full Text]
- Bernstein RK. Dr. Bernsteins diabetes solution: A complete guide to achieving normal blood sugars. Boston: Little, Brown and Co.; 1997: 3512.